BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #3024Biotechnology
$9.54 −$0.83 (-8.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $9.90 +3.77%
Open$10.06
Prev close$10.37
Day range$9.40 – $10.58
Volume967.9K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$4.22M-56.2% YoY
Operating profit-$91.51M-45.7% YoY
Net profit-$87.66M-46.0% YoY
Diluted EPS-$0.68-32.9% YoY
Free cash flow-$57.01M-17.2% YoY
Operating cash flow-$54.86M

Revenue, last 7 quarters

$8.8MMar '25$10.1MJun '25$9.6MSep '25$3.3MDec '25$7.2MMar '26$6.3MJun '26$4.2MSep '26

Net profit, last 7 quarters

$-44.3MMar '25$-56.7MJun '25$-60.0MSep '25$-61.9MDec '25$-61.7MMar '26$-67.3MJun '26$-87.7MSep '26

Diluted EPS by quarter

-0.52Mar '25-0.63Jun '25-0.51Sep '25-0.53Dec '25-1.07Mar '26-0.52Jun '26-0.68Sep '26

Free cash flow by quarter

$-53.9MMar '25$-48.9MJun '25$-48.7MSep '25$-52.6MDec '25$-84.2MMar '26$-58.9MJun '26$-57.0MSep '26

Profitability & balance sheet

Operating margin-1,382.0%
Net margin-1,381.8%
Return on equity-76.4%
Return on assets-56.4%
Return on invested capital-65.5%
Current ratio5.01
Liabilities / assets26.1%
Cash & investments$404.21M
Total debt$52.01M
Net cash (debt)$352.20M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Pretax Profit -$87.61M -$67.20M -$61.69M -$61.85M -$222.80M
Total Operating Revenue $4.22M $6.31M $7.22M $3.31M $31.89M
Total Revenue as Reported $4.22M $6.31M $7.22M $3.31M $31.89M
Basic EPS -$0.68 -$0.52 -$1.07 -$0.53 -$2.18
Operating Expense $95.73M $77.93M $71.34M $67.26M $266.96M
Selling and Admin Expenses $13.47M $13.60M $13.52M $11.27M $42.26M
Gain on Sale of Security -$58,000.00 -$62,000.00 -$305,000.00 -$176,000.00 -$262,000.00
Other Income (Expense) -$58,000.00 -$62,000.00 -$305,000.00 -$176,000.00 -$262,000.00
Non-Operating Interest Expense $192,000.00 $155,000.00 $182,000.00 $208,000.00 $1.14M
Non-Operating Interest Income $4.15M $4.63M $2.91M $2.49M $13.66M
Net Non-Operating Interest Income (Expense) $3.96M $4.47M $2.73M $2.28M $12.53M
Operating Profit -$91.51M -$71.61M -$64.11M -$63.95M -$235.07M
Research & Development $82.25M $64.33M $57.81M $55.99M $224.70M
-General & Admin Expense $13.47M $13.60M $13.52M $11.27M $42.26M
Net Profit -$87.66M -$67.26M -$61.71M -$61.88M -$222.97M
Diluted EPS -$0.68 -$0.52 -$1.07 -$0.53 -$2.18
Net Income to Common Stockholders -$87.66M -$67.26M -$69.20M -$67.02M -$249.52M
Net Income to Parent Company -$87.66M -$67.26M -$61.45M -$55.43M -$203.15M
Minority Interests $0.00 $0.00 -$268,000.00 -$6.45M -$19.81M
Profit from Continuing Operations -$87.66M -$67.26M -$61.71M -$61.88M -$222.97M
Tax $49,000.00 $53,000.00 $28,000.00 $29,000.00 $163,000.00
Preferred Stock Dividends – – $7.75M $11.59M $46.37M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$54.86M -$57.94M -$80.39M -$200.62M -$50.26M
Net cash flow from continuing operations -$54.86M -$57.94M -$80.39M -$200.62M -$50.26M
Net Income from Continuing Operations -$87.66M -$67.26M -$61.71M -$222.97M -$61.88M
Gain/Loss from Continuing Operations $0.00 $0.00 $363,000.00 $49,000.00 –
Depreciation & Depletion & Amortization $3.69M $3.22M $3.27M $13.18M $3.13M
Other Non-Cash Items $4.78M $2.69M $2.09M $5.94M $3.99M
Change in Working Capital $16.72M -$4.46M -$30.65M -$14.62M -$705,000.00
-Change in Receivables $0.00 $0.00 $0.00 $308,000.00 $445,000.00
Net Issuance Payments Of Debt -$1.36M -$993,000.00 -$1.12M -$8.16M -$1.31M
Net Common Stock Issuance $0.00 $0.00 $369.29M – –
Net Preferred Stock Issuance $0.00 $0.00 $0.00 $21.97M $0.00
Proceeds from Stock Option Exercised $4.84M $414,000.00 $3.22M $1.10M $388,000.00
Net Other Financing Charges $0.00 $0.00 $7.50M $13.15M $4.90M
Ending Cash Balance $144.38M $139.39M $164.61M $126.04M $126.04M
Net Change in Cash $4.99M -$25.21M $38.57M -$55.79M $2.83M
Beginning Cash Balance $139.39M $164.61M $126.04M $181.83M $123.20M
Net Cash Flow from Continuing Financing Activities $3.49M -$579,000.00 $378.89M $28.06M $3.98M
Financing Cash Flow $3.49M -$579,000.00 $378.89M $28.06M $3.98M
-Change in Prepaid Assets $2.41M $5.91M -$6.22M -$166,000.00 $398,000.00
-Change in Payables and Accrued Expense $21.88M $2.21M -$17.30M $15.24M $5.13M
-Change in Other Current Assets -$283,000.00 -$4.31M $2.05M $4.84M $388,000.00
-Change in Other Current Liabilities -$3.07M -$1.95M -$1.96M -$2.94M -$3.75M
-Change In Other Working Capital -$4.22M -$6.31M -$7.22M -$31.89M -$3.31M
Net cash flow from investing $56.36M $33.31M -$259.93M $116.77M $49.12M
Net Cash Flow from Continuing Investing Activities $56.36M $33.31M -$259.93M $116.77M $49.12M
Net Investment Purchase and Sale $58.51M $34.24M -$256.15M $120.28M $51.49M
Free Cash Flow -$57.01M -$58.88M -$84.17M -$204.13M -$52.64M
Net PPE Purchase and Sale -$2.16M -$933,000.00 -$3.78M -$3.51M -$2.37M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Total Non-Current Assets $101.25M $91.44M $90.35M $95.82M $95.82M
Total Liabilities $134.73M $105.65M $110.94M $953.38M $953.38M
Total Current Liabilities $82.72M $56.64M $58.39M $82.20M $82.20M
Payables $7.89M $5.65M $7.62M $3.84M $3.84M
-Accounts Payable $7.89M $5.65M $7.62M $3.84M $3.84M
Current Accrued Expenses $29.37M $14.70M $12.50M $25.74M $25.74M
Short-Term Debt and Capital Lease Obligation $23.33M $13.62M $14.26M $15.01M $15.01M
-Current Capital Lease Obligation $23.33M $13.62M $14.26M $15.01M $15.01M
Current Deferred Liabilities $7.95M $12.17M $17.24M $21.19M $21.19M
Other Non-Current Assets $9.34M $9.06M $4.75M $6.81M $6.81M
-Accumulated Depreciation -$58.45M -$54.75M -$51.53M -$48.26M -$48.26M
Other Current Assets $10.43M $12.84M $18.75M $12.53M $12.53M
Restricted Cash $0.00 $0.00 $0.00 $339,000.00 $339,000.00
-Short Term Investments $263.86M $322.06M $356.07M $99.85M $99.85M
-Cash and Cash Equivalents $140.35M $135.36M $160.58M $121.65M $121.65M
Cash and Cash Equivalents & Short-Term Investments $404.21M $457.42M $516.64M $221.50M $221.50M
Total Current Assets $414.64M $470.25M $535.39M $234.37M $234.37M
Total Assets $515.89M $561.69M $625.74M $330.18M $330.18M
-Gross PPE $150.36M $137.13M $137.13M $137.27M $137.27M
Other Current Liabilities $3.16M $2.52M $2.42M $2.63M $2.63M
Total Non-Current Liabilities $52.01M $49.01M $52.55M $871.18M $871.18M
Long Term Debt and Capital Lease Obligation $52.01M $49.01M $51.31M $53.52M $53.52M
Gains/Losses Not Affecting Retained Earnings -$264,000.00 -$129,000.00 $24,000.00 $106,000.00 $106,000.00
Minority Interests $0.00 $0.00 $0.00 -$7.23M -$7.23M
Net PPE $91.91M $82.38M $85.60M $89.01M $89.01M
Retained Earnings -$892.65M -$804.99M -$737.74M -$676.29M -$676.29M
Additional Paid-In Capital $1.27B $1.26B $1.25B $60.19M $60.19M
-Long Term Capital Lease Obligation $52.01M $49.01M $51.31M $53.52M $53.52M
Derivative Product Liabilities $0.00 $0.00 $0.00 $1.21M $1.21M
Non-Current Deferred Liabilities $0.00 $0.00 $1.24M $4.51M $4.51M
Convertible preferred securities $0.00 $0.00 $0.00 $811.83M $811.83M
Total Equity $381.16M $456.05M $514.80M -$623.20M -$623.20M
Stockholders' Equity $381.16M $456.05M $514.80M -$615.97M -$615.97M
Capital Stock $129,000.00 $128,000.00 $128,000.00 $33,000.00 $33,000.00
-Common Stock $129,000.00 $128,000.00 $128,000.00 $33,000.00 $33,000.00
-Accounts Receivable – – – $0.00 $0.00
Other Non-Current Liabilities – – – $116,000.00 $116,000.00
Receivables – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on GENB.

Sign in to join the discussion.

Scroll to Top